Mead Johnson Nutrition Company (MJN) dropped by -0.05 or -0.04 points during the last session to $70.43 per share. One of the highlights of the day was the net money flow figure, which stood at $0.92 million even as the stock accepted $7.2 million in upticks but rejected $6.28 million in downticks. The up/down ratio for the last observation was a 1.15. The 1-week percentage change for the stock price is registered at -1.14%.A block transaction occurred with $1.1 million in upticks and $0 million in downticks while the up/down ratio was calculated to be 0. The stock witnessed a net inflow of $1.1 million at the end of the block trade.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Mead Johnson Nutrition Company has lost 7.23% in the last five trading days and dropped 1.78% in the last 4 weeks. Mead Johnson Nutrition Company has dropped 6.51% during the last 3-month period . Year-to-Date the stock performance stands at -1.78%. Mead Johnson Nutrition Company (NYSE:MJN) witnessed a decline in the market cap on Wednesday as its shares dropped 1.36% or 0.96 points. After the session commenced at $70.48, the stock reached the higher end at $70.845 while it hit a low of $69.25. With the volume soaring to 2,208,001 shares, the last trade was called at $69.5. The company has a 52-week high of $94.4. The company has a market cap of $12,838 million and there are 184,723,440 shares in outstanding. The 52-week low of the share price is $66.66.
Company has reported several Insider transactions to the SEC, on Nov 1, 2016, Anna C Catalano (director) sold 656 shares at 74.99 per share price.On Aug 15, 2016, Kimberly A Casiano (director) sold 710 shares at 89.75 per share price.On Aug 5, 2016, Graciela Monteagudo (SVP&PresAmericas&Glob.Marketg) sold 45,873 shares at 87.69 per share price.
Mead Johnson Nutrition CO Last issued its quarterly earnings results on Jan 26, 2017. The company reported $0.78 EPS for the quarter, missing the analyst consensus estimate by $ -0.03. Analyst had a consensus of $0.81. The company had revenue of $901.60 million for the quarter, compared to analysts expectations of $923.43 million. The companys revenue was down -6.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.78 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Mead Johnson Nutrition CO was Initiated by Berenberg to Sell on Jan 18, 2017.
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The companys mission is to nourish the worlds children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The companys Enfa family of brands, including Enfamil? infant formula, is the worlds leading brand franchise in pediatric nutrition.